Comparing the effects of chemical Ca2+ dyes and R-GECO on contractility and Ca2+ transients in adult and human iPSC cardiomyocytes

Comparing the effects of chemical Ca2+ dyes and R-GECO on contractility and Ca2+ transients in adult and human iPSC cardiomyocytes

We compared commonly used BAPTA-derived chemical Ca<sup>2+</sup> dyes (fura2, Fluo-4, and Rhod-2) with a newer genetically encoded indicator (R-GECO) in single cell models of the heart. We assessed their performance and effects on cardiomyocyte contractility, determining fluorescent sign...

Bibliografiset tiedot
Päätekijät:	Robinson, P, Sparrow, AJ, Psaras, Y, Steeples, V, Simon, JN, Broyles, CN, Chang, Y-F, Brook, FA, Wang, Y-J, Blease, A, Zhang, X, Abassi, YA, Geeves, MA, Toepfer, CN, Watkins, H, Redwood, C, Daniels, MJ
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	Elsevier 2023

Samankaltaisia teoksia

Targeted genetic therapies for inherited disorders that affect both cardiac and skeletal muscle
Tekijä: Psaras, Y, et al.
Julkaistu: (2023)

Measurement of myofilament-localised calcium dynamics in adult cardiomyocytes and the effect of hypertrophic cardiomyopathy mutations
Tekijä: Sparrow, A, et al.
Julkaistu: (2019)

CalTrack: high throughput automated calcium transient analysis in cardiomyocytes
Tekijä: Psaras, Y, et al.
Julkaistu: (2021)

iPSC-cardiomyocytes in the preclinical prediction of candidate pharmaceutical toxicity
Tekijä: Tim Y. T. Lee, et al.
Julkaistu: (2024-02-01)

Macrophages enhance contractile force in iPSC-derived human engineered cardiac tissue
Tekijä: Roberta I. Lock, et al.
Julkaistu: (2024-06-01)

Maturing iPSC-Derived Cardiomyocytes
Tekijä: Bor Luen Tang
Julkaistu: (2020-01-01)

Hypertrophic cardiomyopathy mutations increase myofilament Ca2+ buffering, alter intracellular Ca2+ handling, and stimulate Ca2+-dependent signaling
Tekijä: Robinson, P, et al.
Julkaistu: (2018)

Ca2+ cellular compartment-specific deficits in iPSC-derived neuronal models of Parkinson's disease
Tekijä: Caiazza, MC
Julkaistu: (2022)

Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca²⁺, and activate NFAT and Akt signaling
Tekijä: Robinson, P, et al.
Julkaistu: (2020)

The utilisation of hydrogels for iPSC-cardiomyocyte research
Tekijä: Patel, L, et al.
Julkaistu: (2023)

In Vivo Ca<sub>V</sub>3 Channel Inhibition Promotes Maturation of Glucose-Dependent Ca<sup>2+</sup> Signaling in Human iPSC-Islets
Tekijä: Kaixuan Zhao, et al.
Julkaistu: (2023-03-01)

Mavacamten rescues increased myofilament calcium sensitivity and dysregulation of Ca2+ flux caused by thin filament hypertrophic cardiomyopathy mutations
Tekijä: Sparrow, AJ, et al.
Julkaistu: (2020)

An iPSC-based neural model of sialidosis uncovers glycolytic impairment-causing presynaptic dysfunction and deregulation of Ca2+ dynamics
Tekijä: Haruki Odaka, et al.
Julkaistu: (2021-05-01)

Injectable biodegradable microcarriers for iPSC expansion and cardiomyocyte differentiation
Tekijä: Annalisa Bettini, et al.
Julkaistu: (2024-08-01)

Dynamic alternative polyadenylation during iPSC differentiation into cardiomyocytes
Tekijä: Yanbo Yang, et al.
Julkaistu: (2022-01-01)

Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction.
Tekijä: Sebastian V Rojas, et al.
Julkaistu: (2017-01-01)

GECO, un Gestor de Corpus colaborativo basado en web
Tekijä: Gerardo Sierra, et al.
Julkaistu: (2017-12-01)

The CIRM iPSC repository
Tekijä: Stephen S. Lin, et al.
Julkaistu: (2020-04-01)

Force, Ca-Sensitivity and Contractile Efficiency in Human Myocardium Expressing a Truncated Cardiac Myosin Binding Protein-C
Tekijä: Griffiths, P, et al.
Julkaistu: (2010)

CiRA iPSC seed stocks (CiRA's iPSC Stock Project)
Tekijä: Tadaaki Hanatani, et al.
Julkaistu: (2021-01-01)

In vitro Differentiation of Human iPSC-derived Cardiovascular Progenitor Cells (iPSC-CVPCs)
Tekijä: Agnieszka D’Antonio-Chronowska, et al.
Julkaistu: (2020-09-01)

Correction of DMD in human iPSC-derived cardiomyocytes by base-editing-induced exon skipping
Tekijä: Peipei Wang, et al.
Julkaistu: (2023-03-01)

Transcriptome-wide RNA 5-methylcytosine profiles of human iPSCs and iPSC-derived cardiomyocytes
Tekijä: Szu-Ying Chen, et al.
Julkaistu: (2024-12-01)

Omecamtiv mecarbil augments cardiomyocyte contractile activity both at resting and systolic Ca2+ levels
Tekijä: Arnold Péter Ráduly, et al.
Julkaistu: (2023-04-01)

In vitro Differentiation of Human iPSC-derived Retinal Pigment Epithelium Cells (iPSC-RPE)
Tekijä: Agnieszka D’Antonio-Chronowska, et al.
Julkaistu: (2019-12-01)

The role of phosphofructokinase P in hypertrophy of iPSC-derived human cardiomyocytes
Tekijä: Katarzyna Kmiotek, et al.
Julkaistu: (2024-11-01)

Unchain My Heart: Integrins at the Basis of iPSC Cardiomyocyte Differentiation
Tekijä: Rosaria Santoro, et al.
Julkaistu: (2019-01-01)

Effects of arginase inhibition on myocardial Ca2+ and contractile responses
Tekijä: Jin Sun Cho, et al.
Julkaistu: (2022-07-01)

Contractile Work Contributes to Maturation of Energy Metabolism in hiPSC-Derived Cardiomyocytes
Tekijä: Bärbel M. Ulmer, et al.
Julkaistu: (2018-03-01)

Microscopy-based cellular contractility assay for adult, neonatal, and hiPSC cardiomyocytes
Tekijä: Sérgio Scalzo, et al.
Julkaistu: (2022-03-01)

Evaluation of MYBPC3 trans-splicing and gene replacement as therapeutic options in human iPSC-derived cardiomyocytes
Tekijä: Prondzynski, M, et al.
Julkaistu: (2017)

iPSC for modeling neurodegenerative disorders
Tekijä: Valeria Valadez-Barba, et al.
Julkaistu: (2020-12-01)

Reduced ER-mitochondrial contact sites and mitochondrial Ca2+ flux in PRKN-mutant patient tyrosine hydroxylase reporter iPSC lines
Tekijä: Mutsumi Yokota, et al.
Julkaistu: (2023-09-01)

Characterisation of dynamic cellular processes in human stem cell models of inherited cardiomyopathy using genetically encoded reporters
Tekijä: Broyles, CN
Julkaistu: (2019)

Length-Dependent Activation of Contractility and Ca-Transient Kinetics in Auxotonically Contracting Isolated Rat Ventricular Cardiomyocytes
Tekijä: Oleg Lookin, et al.
Julkaistu: (2019-12-01)

Increases in [IP3]i aggravates diastolic [Ca2+] and contractile dysfunction in Chagas' human cardiomyocytes.
Tekijä: Alfredo Mijares, et al.
Julkaistu: (2020-04-01)

Tauroursodeoxycholic acid mitigates high fat diet-induced cardiomyocyte contractile and intracellular Ca2+ anomalies.
Tekijä: Subat Turdi, et al.
Julkaistu: (2013-01-01)

Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology
Tekijä: Maria R. Pozo, et al.
Julkaistu: (2022-01-01)

Sarcomere Disassembly and Transfection Efficiency in Proliferating Human iPSC-Derived Cardiomyocytes
Tekijä: Qianliang Yuan, et al.
Julkaistu: (2022-01-01)

Functional and molecular effects of TNF-α on human iPSC-derived cardiomyocytes
Tekijä: Anita Saraf, et al.
Julkaistu: (2021-04-01)